Skip to main content
TASLY PHARMACEUTICAL GROUP CO.,LTD. logo

TASLY PHARMACEUTICAL GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 600535 ISIN · CNE000001C81 LEI · 300300JB9F71F58FIC88 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,889 across all filing types
Latest filing 2020-12-28 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600535

About TASLY PHARMACEUTICAL GROUP CO.,LTD.

http://www.tasly.com

Tasly Pharmaceutical Group Co., Ltd. specializes in the research, development, and production of modern Traditional Chinese Medicine (TCM), biological products, and chemical pharmaceuticals. The company is primarily known for its flagship cardiovascular treatment, Compound Danshen Dripping Pills, which represents a significant advancement in the modernization and standardization of herbal medicine. Its therapeutic portfolio covers cardiovascular, cerebrovascular, digestive, and metabolic diseases, as well as oncology. Tasly utilizes high-tech manufacturing processes and maintains a strong focus on R&D to bridge traditional therapies with modern clinical standards. The organization also explores digital health solutions and innovative drug delivery systems to enhance its comprehensive healthcare offerings.

Recent filings

Filing Released Lang Actions
关于产品新纳入国家医保目录的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company about a product being newly included in the National Medical Insurance Directory. It details the product, its approval, and the expected impact on the company. There are no financial statements, no detailed financial performance data, no regulatory certifications, or meeting materials. The document is a regulatory announcement about a product listing and its implications, which fits best under Regulatory Filings (RNS) as it does not match any other specific category such as financial reports, management changes, or capital updates.
2020-12-28 Chinese
关于控股股东部分股权质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the pledge of shares by the controlling shareholder of the company. It details the number of shares pledged, the proportion of total shares, the purpose of the pledge, and risk mitigation measures. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledging activity by major shareholders, which fits the category of Capital/Financing Update (CAP). The document length is under 5,000 characters and it is not an announcement of a report publication but a direct disclosure of a financing-related event. Therefore, the appropriate classification is CAP with high confidence.
2020-12-11 Chinese
关于股东部分股权质押的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the pledge of shares by certain shareholders of the company. It details the number of shares pledged, the shareholders involved, the proportion of shares pledged relative to total holdings and company stock, and risk mitigation measures. There is no financial data, earnings information, or detailed report content. The document is a formal disclosure of a shareholder's share pledge, which fits the category of a regulatory announcement about shareholding changes but not a major shareholding notification (which typically involves crossing ownership thresholds). It is not a full financial report, earnings release, or management report. Given the nature of the content, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-12-08 Chinese
关于控股股东部分股份解除质押的公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement by the company TianShiLi Pharmaceutical Group Co., Ltd. regarding the release of a portion of pledged shares by its controlling shareholder. It details the number of shares released from pledge, the remaining pledged shares, and the shareholding percentages. The content focuses on share pledge and release activities, which are related to changes in share capital structure but do not involve new share issuance or capital increase. The document is relatively short (2141 characters) and is a formal disclosure of share pledge status. This fits the category of Transaction in Own Shares (POS), which covers company buying back or selling its own shares or changes in pledged shares. It is not an earnings report, management report, or regulatory filing unrelated to share transactions. Therefore, the correct classification is POS with high confidence.
2020-12-01 Chinese
关于股份回购进展情况的公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement from a company regarding the progress of its share repurchase program. It details the number of shares repurchased, the price range, total amount spent, and references previous announcements about the repurchase plan. The document is short (994 characters) and focuses on reporting the status of the share buyback, which aligns with the category for reporting transactions in own shares. It is not a full financial report or earnings release, nor is it a regulatory filing or announcement of a report publication. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2020-12-01 Chinese
关于控股股东部分股份解质押及质押的公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from the company regarding the pledge and release of shares by the controlling shareholder. It details the number of shares pledged, released, and the proportion of total shares involved. There is no financial statement, earnings data, or management discussion. The document is focused on share pledge activities, which relate to capital structure and financing. It is not a full financial report, earnings release, or regulatory certification. The content fits the category of Capital/Financing Update (CAP) as it provides updates on share pledging activities by the controlling shareholder, which is a financing activity.
2020-11-24 Chinese

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.